Testing COVID-19 tests faces methodological challenges
Top Cited Papers
Open Access
- 1 October 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Clinical Epidemiology
- Vol. 126, 172-176
- https://doi.org/10.1016/j.jclinepi.2020.06.037
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCREurosurveillance, 2020
- Laboratory Measurement's Contribution to the Replication and Application Crisis in Clinical ResearchClinical Chemistry, 2019
- Inadequate Reporting of Analytical Characteristics of Biomarkers Used in Clinical Research: A Threat to Interpretation and Replication of Study FindingsClinical Chemistry, 2019
- Setting clinical performance specifications to develop and evaluate biomarkers for clinical useAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2019
- STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaborationBMJ Open, 2016
- Updating standards for reporting diagnostic accuracy: the development of STARD 2015Research Integrity and Peer Review, 2016
- From biomarkers to medical tests: The changing landscape of test evaluationClinica Chimica Acta; International Journal of Clinical Chemistry, 2014
- Beyond Diagnostic Accuracy: The Clinical Utility of Diagnostic TestsClinical Chemistry, 2012
- Reliability of real-time reverse-transcription PCR in clinical diagnostics: gold standard or substandard?Expert Review of Molecular Diagnostics, 2009
- Evidence base of clinical diagnosis: Designing studies to ensure that estimates of test accuracy are transferableBMJ, 2002